- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01317381
ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ((Greenpep))
March 15, 2011 updated by: University of Zurich
ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill
ICG- Leberfunktionstest versus "neue" Biomarker als prognostischer Marker bei intensivmedizischen Patienten
Study Overview
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zurich, Switzerland
- Recruiting
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Admitted ICU Patients
Description
Inclusion criteria: Gruppe 1:
- Intensiv-Patienten mit Verbrennungen > 10% der Körperoberfläche
- Alter > 18
Gruppe 2:
- Intensivpatienten nach grossen chirurgischen Eingriffen
- Alter > 18
Gruppe 3:
- Polytraumatisierte, intensivpflichtige Patienten
- Alter > 18
Exclusion criteria: • Alter < 18
- Schwangerschaft
- Einschluss in eine andere Studie
- Moribunde Patienten
- Patienten, die kein Deutsch verstehen
- Jodunverträglichkeit
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
ICU patients
Admitted patients to the ICU
|
Blood draw
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2010
Study Completion
May 1, 2011
Study Registration Dates
First Submitted
August 23, 2010
First Submitted That Met QC Criteria
March 15, 2011
First Posted (Estimate)
March 17, 2011
Study Record Updates
Last Update Posted (Estimate)
March 17, 2011
Last Update Submitted That Met QC Criteria
March 15, 2011
Last Verified
August 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Version 2.0. 08.12.2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critically Ill Patients
-
Third Military Medical UniversityNot yet recruiting
-
Mahidol UniversityNot yet recruiting
-
National Institutes of Health Clinical Center (CC)CompletedCritically Ill Surgical PatientsUnited States
-
Nanfang Hospital, Southern Medical UniversityCompletedHyperglycemia in Critically Ill PatientsChina
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingRBCs Transfusion in Critically-ill Patients
-
University Hospital, RouenCompletedSedated Patients | Critically Ill Patients Under Mechanical VentilationFrance
-
The Cleveland ClinicCompletedCritically Ill Patients | Cardiovascular Surgery Telemetry PatientsUnited States
-
China Medical University HospitalRecruitingCritically Ill PatientsTaiwan
-
Hospital Sao DomingosCompletedCritically Ill PatientsBrazil
-
Ain Shams UniversityUnknownCritically-ill PatientsEgypt
Clinical Trials on Observational
-
Massachusetts General HospitalRecruiting
-
Taysha Gene Therapies, Inc.Withdrawn
-
University Hospital, AntwerpUniversiteit AntwerpenUnknownType 1 Diabetes | Diastolic Dysfunction | Coronary Artery CalcificationsBelgium
-
St. Louis UniversityRecruitingVertebral Artery StenosisUnited States
-
University Hospital, Basel, SwitzerlandCompletedPostoperative Complications | Intraoperative Complications | Patient Safety | Risk ManagementNew Zealand, Switzerland, United States, Netherlands, Spain, Austria, Turkey, United Kingdom, Australia, Greece, Ireland, Italy
-
University of Castilla-La ManchaRecruitingKnee OsteoarthritisSpain
-
University of ManitobaCompletedObesity | Pregnancy | Cesarean SectionCanada
-
Drexel UniversityCompletedOsteoporosisUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedAcute Leukemia | Chemotherapy-Induced Gut Barrier DamageUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); National Center for Advancing Translational...CompletedHead and Neck Cancer | Chronic Obstructive Pulmonary Disease | Lung CancerUnited States